Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0B6WP
|
|||
| Former ID |
DIB004595
|
|||
| Drug Name |
Improved influenza vaccine
|
|||
| Synonyms |
GSK-2186877A; GSK-576389A; Improved influenza vaccine, GlaxoSmithKline; New generation seasonal influenza vaccine, GlaxoSmithKline; New influenza vaccine, GlaxoSmithKline; Subunit vaccine (elderly influenza, new delivery), GlaxoSmithKline
Click to Show/Hide
|
|||
| Indication | Influenza virus infection [ICD-11: 1E30-1E32] | Phase 3 | [1] | |
| Company |
GlaxoSmithKline plc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00529516) Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.